May 14, 2020 / 12:55 PM / 23 days ago

BRIEF-European Commission Approves Adcetris For Treatment Of Systemic Anaplastic Large Cell Lymphoma

May 14 (Reuters) - Takeda Pharmaceutical Co Ltd:

* EUROPEAN COMMISSION APPROVES ADCETRIS® (BRENTUXIMAB VEDOTIN) FOR TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY UNTREATED SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below